1. In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy.
- Author
-
Lin MS, Tseng YH, Chen MY, Chung CM, Tsai MH, Wang PC, Chang JJ, Chen TH, and Lin YS
- Subjects
- Acute Disease, Child, Child, Preschool, Databases, Factual, Female, Humans, Immunoglobulins, Intravenous adverse effects, Infant, Infant, Newborn, Male, Myocarditis diagnosis, Myocarditis mortality, Retrospective Studies, Risk Assessment, Risk Factors, Steroids adverse effects, Taiwan epidemiology, Time Factors, Treatment Outcome, Immunoglobulins, Intravenous administration & dosage, Myocarditis drug therapy, Patient Discharge, Steroids administration & dosage
- Abstract
Background: High-dose steroids and intravenous immunoglobulin (IVIG) are controversial treatments for pediatric patients with acute myocarditis. This study aimed to investigate their efficacies in the Taiwanese pediatric population., Methods: This study evaluated 5563 acute myocarditis patients from the Taiwan's National Health Insurance Research Database and identified 1542 pediatric patients hospitalized for acute myocarditis between January 1, 2001 and December 31, 2011. The exclusion criteria were age of > 11 years, associated cardiovascular comorbidities, autoimmune disease, malignancy before the index hospitalization, extracorporeal membrane oxygenation, intra-aortic balloon pumping, and dual therapy using IVIG and high-dose steroids., Results: After 2:1 propensity score matching, we identified 208 subjects without steroid therapy and 104 subjects who received high-dose steroids. The mean age in that cohort was 2.6 ± 2.9 years, and high-dose steroid therapy had no significant effects on major in-hospital complications and post-discharge outcomes. After 2:1 propensity score matching, we identified 178 subjects without IVIG therapy and 89 subjects who received IVIG. The mean age in that cohort was 2.0 ± 2.1 years, and IVIG had no significant effects on the major outcomes., Conclusions: The present study revealed that high-dose steroid or IVIG therapy had no significant effects on major in-hospital complications, late heart failure hospitalization, and long-term mortality.
- Published
- 2019
- Full Text
- View/download PDF